Healthcare 3D Printing Market to Grow with a CAGR of 4.87% through 2028
Rising Awareness for Amniocentesis are expected to
drive the Global Amniocentesis Needle Market in the forecast period 2024-2028.
According to TechSci Research report, “Amniocentesis Needles Market – Global Industry Size, Share, Trends, Competition
Forecast & Opportunities, 2028”, the Global Amniocentesis Needle Market
stood at USD 160.02million in 2022 and is anticipated to grow with a CAGR of 2.23%
in the forecast period, 2024-2028. The amniocentesis market is projected to
exhibit steady growth in the foreseeable future. This growth can be attributed
to several key factors, including the increasing median age at which women have
their first child, the rising prevalence of congenital diseases, and the strong
trust people place in amniocentesis as a reliable diagnostic tool. Amniocentesis
boasts an impressive accuracy rate of nearly 99.4%, making it a highly
dependable method for detecting genetic or chromosomal abnormalities in the
developing fetus. This test is capable of identifying a wide range of genetic
disorders, including conditions such as Down syndrome, Edward's syndrome,
Tay-Sachs disease, Huntington's disease, sickle cell disease, and cystic
fibrosis. It plays a crucial role in diagnosing these potential complications
in the unborn child. Given the test's exceptional reliability, it has garnered
widespread adoption across various healthcare facilities, paving the way for
market expansion throughout the forecast period.
Amniocentesis is a medical procedure used during
pregnancy to obtain a sample of amniotic fluid from the amniotic sac
surrounding the developing fetus. This procedure involves inserting a thin,
hollow needle through the mother's abdominal wall and into the amniotic cavity.
A small amount of amniotic fluid, which contains fetal cells and other
substances, is withdrawn for various diagnostic purposes. Amniocentesis is
typically performed between the 15th and 20th weeks of pregnancy. Applications
of amniocentesis include: Genetic Testing: Amniocentesis allows for the
examination of the fetal chromosomes, providing valuable information about the
baby's genetic makeup. It can detect chromosomal abnormalities such as Down
syndrome, Edwards syndrome, and Patau syndrome. Neural Tube Defect Screening:
The procedure can identify neural tube defects such as spina bifida and
anencephaly by analyzing the levels of alpha-fetoprotein (AFP) in the amniotic
fluid. Lung Maturity Assessment: Amniocentesis can assess the maturity of the
fetal lungs by measuring the concentration of surfactant, a substance essential
for lung function. This information is crucial if early delivery is being
considered. Infection Diagnosis: It can help diagnose infections in the fetus,
such as congenital rubella or toxoplasmosis, by analyzing the amniotic fluid
for the presence of pathogens. Rhesus (Rh) Factor Testing: Amniocentesis can
determine the Rh factor of the fetus's blood, which is essential when the
mother is Rh-negative, and Rh incompatibility is a concern. Gender
Determination: Although not typically the primary purpose, amniocentesis can
also reveal the gender of the fetus. Amniocentesis is a valuable diagnostic
tool that provides essential information to expectant parents and healthcare
providers, enabling them to make informed decisions about the pregnancy and
prepare for the care of the baby, especially when there are concerns about
fetal health or genetic conditions.
Browse over XX market data Figures spread
through XX Pages and an in-depth TOC on "Global
Amniocentesis Needle Market.”
Several drivers contribute to the growth of the global
Amniocentesis Market: Increasing Maternal Age: The trend of delayed
childbearing, with women opting to have children at older ages, has led to a
higher risk of chromosomal abnormalities and genetic disorders in newborns.
Consequently, there is a growing demand for amniocentesis procedures among
older expectant mothers. Rising Awareness and Education: Increased awareness
among pregnant individuals and healthcare providers about the importance of
prenatal testing and early diagnosis of fetal conditions has driven the demand
for amniocentesis as a reliable diagnostic tool. Advancements in Technology:
Continuous innovations in amniocentesis techniques and equipment, including
safer and more precise needles, have made the procedure more accessible and
reliable, contributing to its adoption. Growing Incidence of Genetic Disorders:
The prevalence of genetic disorders, such as Down syndrome and cystic fibrosis,
continues to rise, necessitating more prenatal testing procedures like
amniocentesis to identify these conditions early. Maternal Choice and Informed
Decision-Making: Increasingly, expectant parents are choosing to undergo
amniocentesis to gain valuable information about their baby's health,
empowering them to make informed decisions during pregnancy. Expanding
Healthcare Infrastructure: The development of healthcare infrastructure,
particularly in emerging economies, has made prenatal care and related
procedures, including amniocentesis, more accessible to a broader population. Genetic
Counseling Services: The availability of genetic counseling services helps
individuals and couples understand the benefits and risks associated with
amniocentesis, further promoting its utilization. Regulatory Support: Favorable
regulatory environments and adherence to stringent quality and safety standards
instill confidence in both healthcare professionals and patients, encouraging
the use of amniocentesis. These drivers collectively contribute to the growth
and adoption of amniocentesis as a vital component of prenatal care, ensuring
the well-being of both expectant mothers and their unborn children.
The Global Amniocentesis Needle Market is segmented
into type, procedure, regional distribution, and company.
Based on procedure, the market is segmented into Amniocentesis
Procedures, Amnioreduction Procedures, Fetal Blood Transfusion Procedures, Amnioinfusion
Procedures, Cordocentesis Procedures. The Amniocentesis Procedures segment is
expected to rise in the forecast period. This is attributed due to their
broader diagnostic applications. Amniocentesis involves extracting amniotic
fluid, enabling the diagnosis of various genetic disorders and chromosomal
abnormalities, making it a versatile choice. In contrast, other procedures,
such as amnioreduction, fetal blood transfusion, and amnioinfusion, are more
specific interventions primarily focused on managing complications like
polyhydramnios or delivering therapeutic interventions. Cordocentesis is a
highly specialized procedure for fetal blood sampling and transfusion. While
essential in specific medical scenarios, these procedures cater to a narrower
range of conditions, resulting in amniocentesis maintaining its dominance in
prenatal diagnosis.
Based on region, the market is segmented into North
America, Europe, Asia Pacific, Central & South America, Middle East &
Africa. The North America segment was dominated the market in 2022. This is due
to the rising government initiatives and an increasing number of amniocentesis
procedures, are driving the growth of the market in this region. The developed
healthcare system in the United States is augmenting the demand for advanced
products which is accelerating the growth of amniocentesis needles with
advanced technology. Added to that, a concern of the general population in the
North America region about the genetic disorders in a newborn is propelling the
demand for amniocentesis procedure.
Major companies operating in Global
Healthcare 3D Printing Market are:
- Becton Dickinson and Company
- The Cooper Companies, Inc.
- Cook Medical Incorporated
- RI.MOS. srl
- Medtronic Plc
- Somatex Medical Technologies
- COOK Medical
- Smiths Medical
- Biopsybell
- IMD
Download Free Sample Report
Customers can also request for 10%
free customization on this report.
“The Global Amniocentesis Needle Market is driven by
several compelling factors that collectively contribute to its rapid growth and
innovation in the healthcare industry. The trend of delayed childbearing, with
women opting to have children at older ages, has led to a higher risk of
chromosomal abnormalities and genetic disorders in newborns. Consequently,
there is a growing demand for amniocentesis procedures among older expectant
mothers, propell the growth of Global Amniocentesis Needle Market. Additionally,
The prevalence of genetic disorders, such as Down syndrome and cystic fibrosis,
continues to rise, necessitating more prenatal testing procedures like
amniocentesis to identify these conditions early, contributes to foster the
demand for Global Amniocentesis Needle Market in the forecast period” said Mr.
Karan Chechi, Research Director with TechSci Research, a research-based
management consulting firm.
“Amniocentesis Needles Market -
Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028
Segmented By Type (100 to 1500 mm Needles, Larger than 150 mm Needles, Smaller than 100 mm Needles), By Procedure (Amniocentesis Procedures, Amnioreduction Procedures, Fetal Blood Transfusion Procedures, Amnioinfusion Procedures, Cordocentesis Procedures), By Region and Competition” has evaluated
the future growth potential of Global Amniocentesis Needle Market and provides
statistics & information on market size, structure and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Amniocentesis Needle Market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]
Website: https://www.techsciresearch.com